Seeking Alpha
12 Feb 2026, 19:16 UTC · 31w ago
Verdict
Headline takes no side. We score NBIX +0.10 — slightly bullish.
+0.10slightly bullish
More positive than 47% of ticker scores this week
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
More positive than 35% of relationship scores this week
[mutual] Neurocrine Biosciences' Ingrezza is compared in a head-to-head study against Teva's Austedo.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
+1.5%
Price agrees with the score
$139.49 vs $137.44 close before publication (Feb 11) · not market-adjusted
NBIX chart →
